Organic compounds -- part of the class 532-570 series – Organic compounds – Carboxylic acid esters
Patent
1997-12-18
2000-01-11
Barts, Samuel
Organic compounds -- part of the class 532-570 series
Organic compounds
Carboxylic acid esters
562496, C07C 6976
Patent
active
060138327
ABSTRACT:
The present invention relates to a process for the production of benzene derivatives represented by formula (I), which are useful as intermediates for agricultural chemicals, fine chemical products or pharmaceuticals such as anti inflammatory analgesics. The process includes reacting a compound of chemical formula (II) with a hydroformylating agent and a halogenating agent. ##STR1##
REFERENCES:
patent: 3919206 (1975-11-01), Patchornik et al.
patent: 5026687 (1991-06-01), Yarchoan et al.
patent: 5073627 (1991-12-01), Curtis et al.
patent: 5116964 (1992-05-01), Capon et al.
patent: 5225538 (1993-07-01), Capon et al.
patent: 5349053 (1994-09-01), Landolfi
patent: 5409698 (1995-04-01), Anderson et al.
patent: 5419900 (1995-05-01), Lane et al.
patent: 5428130 (1995-06-01), Capon et al.
patent: 5503841 (1996-04-01), Doyle et al.
patent: 5521288 (1996-05-01), Linsley et al.
patent: 5580859 (1996-12-01), Felgner et al.
patent: 5593972 (1997-01-01), Weiner et al.
patent: 5643578 (1997-07-01), Robinson et al.
patent: 5656297 (1997-08-01), Bernstein et al.
patent: 5693762 (1997-12-01), Queen et al.
Phase Transfer Catalyst principles and technique; Starks et al, pp. 1-11, 1981.
Kuby, Janis, Chapter 11 Immunology, W. H. Freeman and Co., (1992).
Engelhard, Victor H., "How Cells Process Antigens.", Scientific American, Aug. 1994.
Chow, Yen-Hung, et al. "Improvement of Hepatitis B Virus DNA Vaccines by Plasmids Coexpressing Hepatitis B surface Antigen and Interleukin-2" J. Virol., 71 (1):169-178, 1997.
Xiang, et al. "Manipulation of the Immune Response to a Plasmid-Encoded Viral Antigen by Coinoculation with Plasmids Expressing Cytokines," Immunity, 2:129-135, (1995).
Conry, R. M. et al. "Selected Strategies to Augment Polynucleotide Immunization." Gene Therapy, 3:67-74 (1996).
Iwasaki, A. et al. "Enhanced CTL Responses Medicated by Plasmid DNA Immunogens Encoding Costimulatory Molecules and Cytokines." J. Immunol.,158:4591-4601 (1997).
Geissler, M., et al. "Enhancement of Cellular and Humoral Immune Responses by Hepatitis C. Virus Core Protein Using DNA-Based Vaccines Augmented with Cytokine-Expressing Plasmids." J. Immonol., 158:1231-1237 (1997).
Kim, J. J., et al. "In Vivo Engineering of Cellular Immune Response by Coadministration ofIL-12 Expression Vector with a DNA Immunogen." J. Immunol, 158:816 826 (1997).
Rosenberg, S. A., et al. "Immunologic and Therapeutic Evaluation of a Synthetic Peptide Vaccine for the Treatment of Patients with Metastatic Melanoma." Nature Medicine, 4(3):321-327 (1998).
Wolff, J. A., et al. "Direct Gene Transfer Into Mouse Muscle in Vivo." Science (Wash DC). 247:1465-1468.
Tang, D. C., et al. "Genetic Immunization Is A Simple Method for Eliciting an Immuno Response." Nature (Lond.) 356:152-154.
Ulmer, J. B., et al. "Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral Protein." Science (Wash. DC). 259:1745-1749 (1993).
Wang, B., et al. "Gene Inoculation Generates Immune Responses Against Human Immunodeficiency Virus Type 1." Proc. Natl. Acad. Sci. USA. 90:4156-4160 (1993).
Fynan, E. F., et al. "DNA Vaccines: Protective Immunizatins by Parenteral, Mucosal, and Gene-Gun Inoculations." Proc. Natl. Acad. Sci. USA. 90:11478-11482 (1993).
Ulmer, J. B., et al., "Protective Immunity by Intramuscular Injection of Low Doses of Influenza Virus DNA Vaccines." Vaccine 12:1541-1544 (1994).
Donnelly, J. J., et al. "Preclinical Efficacy of a Prototype DNA Vaccine: Enhance Protection Against Antigenic Drift in Influenza Virus." Nature Med., 1:583-587 (1995).
Cohen, J., "Naked DNA Points the Way to Vaccines." Science (Wash. DC) 259:1691-1692 (1993).
Donnelly, J. J., et al., "Immuization with DNA." J. Immunol, Methods. 176:145-152 (1994).
Ertl, H. C., et al. "Novel Vaccine Approaches." J. Immunol. 156:3579-3582 (1996).
McDonnell, W. M., et al. "DNA Vaccines." N. Engl. J. Med. 334:42-45 (1996).
Baltimore, D., "Lessons from People with Nonprogressive HIV Infection." N. Engl. J. Med., 332:259-260 (1995).
Cao, Y., et al., "Virologic and Immunologic Characterization of Long-Term Survivors of Human Immunodeficiency Virus Type 1 Infection." N. Engl. J. Med. 332:201-208 (1995).
Haynes, B. F., et al. "Toward an Understanding of the Correlates of Protective Immunity to HIV Infection." Science (Wash. DC). 271:324-328 (1996).
Musey, L., et al. "Cytotoxic T-Cell Responses, Viral Load and Disease Progression in Early Human Immunodeficiency Virus Type 1 Infection." N. Engl. J. Med., 337:1267-1274 (1997).
Wang, B., et al. "DNA Inoculation Induces Neutralizing Immune Responses Against Human Immunodeficiency Virus type 1 in Mice and Nonhuman Primates." DNA Cell Biol. 12:799-80 (1993).
Shiver, J., W., et al. "Cytotoxic T Lymphocyte and Helper T Cell Responses Following HIV Polynucleotide Vaccination." Ann. NY Acad. Sci. 772:198-208 (1995).
Wang, B., et al. "Induction of Humoral and Cellular Immune Responses to the Human Immunodeficiency Type 1 Virus in Nonhuman Primates by in Vivo DNA Inoculation." Virology, 211:102-112 (1995).
Shiver, J. W., et al. "Humoral and Cellular Immunities Elicited by HIV-1 DNA Vaccination." J. Pharm. Sci. 85:1317-1324 (1996).
Liu, M. A., et al. "Vaccination of Mice and Nonhuman Primates Using HIV Gene Contain DNA." Antibiot. Chemother. 48:100-104 (1996).
Yasutomi, Y., et al. "Simian Immunodeficiency Virus-Specific Cytotoxic T-Lymphocyte Induction through DNA Vaccination of Rheses Monkeys." J. Virol. 70:678-681 (1996).
Lekutis, C., et al. "HIV-1 Env DNA Vaccine Administered to Rhesus Monkeys Elicits MHC Class II-Restricted CD4 T Helper Cells that Secrete IFN-.gamma. and TNF-.alpha.." J. Immunol. 158:4471-4477 (1997).
Lu, S., "Simian Immunodeficiency Virus DNa Vaccine Trial in Macaques." J. Virol. 70:3978-3991 (1996).
Boyer, J. D., et al. "Protection of Chimpanzees from High-Dose Heterolgous HIV-1 Challenge by DNA Vaccination." Nature Med., 3:526-532 (1997).
Kennedy, R. C., "DNA Vaccination for HIV." Nature Med. 3:501-502 (1997).
Letvin, N. L., et al. "Potent, Protective Anti-HIV Immune Responses Generated by Bimodal HIV Envelope DNA Plus Protein Vaccination." Proc. Natl. Aca. Sci. USA. 94:9379-9383 (1997).
Tsuji, T., et al. "Enhancement of Cell-Mediated Immunity Against HIV-1 Induced by Coinoculation of Plasmid-Encoded HIV-1 Antigen with Plasmid Expressing IL-12." J. Immunol. 158:4008-4013 (1997).
Okada, E., et al. Intranasal Immunization of a DNA Vaccine with IL-12- and Granulocyte-Macrophage Colony-Stimulated Factor (GM-SCF)-Expressing Plasmids in Liposomes Induces Strong Mucosal and Cell-Mediated Immune Responses Against HIV-1 Antigens.: J. Immunol. 159:5107-5113 (1997).
Geissler, M., et al. "Inhibitory Effects of Chronic Ethanol Consumption on Cellular Immune Responses to Hepatitis C Virus Core Protein are Reversed by Genetic Immunizations Augmented with cytokine-Expressing Plasmids." J. Immunol. 159:5107-5113 (1997).
Raz, E., et al. "Systemic Immunological Effects of Cytokine Genes Injected into Skeletal Muscle." Proc. Natl. Aca. Sci. USA. 90:4523-4257 (1993).
Landolfi, N. F., "A chimeric IL-2/Ig Molecule Possess the Functional Activity of Both Proteins." J. Immunol. 146:915-919 (1991).
Zheng, X. X., et al. "Administration of Noncytolytic IL-10/Fc in Murine Models of Lipopolysaccharide-Induced Septpic Shock and Allogeneic Islet Transplantation." J. Immunol. 154: 5590-5600 (1995).
Nickerson, P., et al. "Prolonged Islet Allograft Acceptance in the Absence of Interleukin 4 Expression." Transpl Immunol. 4:81-85 (1996).
Montgomery, D. L., et al. "Heterologous and Homologous Protection Against Influenza A by DNA Vaccination: Optimization of DNA Vectors." DNA and Cell Bio. 12:777-783 (1993).
Chapman, B. S., et al. "Effect of Intron A from Human Cytomegalovirus (Towne) Immediate-Early Gene on Heterologous Expression in Mammalian Cells." Nuc. Acids Res 19:3979-3986 (1991).
Davies, M. V., et al. "The Sequence Context of the Initiation Codon in the Encephalomyocarditis Virus Leader Modulates Efficiency of Internal Translation Initiation." J. Virol. 66:1924-1932 (1992).
Kashima, N., et al. "Unique Structure of Murine Interleukin-2 as Deduced from Cloned
Cho Eun Jung
Cho Sung Min
Choi Tae Gun
Kim Jeong Soo
Kim Ki Sug
Barts Samuel
Kolon Industries Inc.
LandOfFree
Process for the production of benzene derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for the production of benzene derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for the production of benzene derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1463719